Jie-Huei Wang
office: Room 450
Phone: (05)2720411#66113
Fax: (05)2720497
Email: jhwang@ccu.edu.tw
研究領域
|
|
|
|
個人網站
ResearcgGate: https://www.researchgate.net/profile/Jie-Huei-Wang-2/research
Google Scholar: https://reurl.cc/5baKE7
學歷
經歷
學術服務
Journal Reviewer (Number of Reviews)
By Recent 5 Years:
2026: BMC Medical Informatics and Decision Making (1); Statistics in Medicine (1)
2025: BioData Mining (1); Bioinformatics (1); IEEE/ACM Transactions on Computational Biology and Bioinformatics (TCBB) (1); npj Digital Medicine (1)
2024: BMC Medical Informatics and Decision Making (1); BMC Medical Research Methodology (1); Machine Learning (1); Mathematics (1)
2023: BMC Bioinformatics (1)
2022: Computational Statistics (2)
2021: Current Pharmaceutical Design (1); Statistical Methods in Medical Research (2)
學術著作
期刊論文 *: corresponding author
Lin CT, Chiou YS, Yang JR, Wang JH, Yen MC, Li CR & Shih CL* (2026-02). A systematically optimized two-dose differential strategy integrating stable isotope tracing and mass shift defect filtering for reducing false positives in high-resolution mass spectrometry–based drug metabolite profiling. Talanta, 129582. (SCIE)
Chiang CH, Liu WC, Wu ZH, Wang JH & Shih CL* (2026-02). Evidence-based management strategies for adult trigger digits: A systematic review and network meta-analysis of randomized controlled trials. Annals of Physical and Rehabilitation Medicine, 69(4):102074. (SCIE)
Wang JH*, Wu ZH, Lu HC & Guo TY (2025-12). Robust Cancer Biomarker Identification from Matched Transcriptomic Data via Bootstrapped Regularized Conditional Logistic Regression. Cancer Informatics, 24:1-22. (ESCI)
Wang JH*, Guo TY, Pai YY, Hou PL, Kumari Himani, Chan MWY (2025-10). Cancer Classification and Functional Pathway Discovery Using TCGA Transcriptomic Profiles: A Matched Case-Control Framework. Journal of Bioinformatics and Computational Biology, 23(5):2550015. (SCIE)
Lo SF, Chiou YS, Wang JH, Wu ZH, Yen MC, Shih CL* (2025-09). Modified two-dose difference with stable isotope tracing workflow using mass shift defect filtering substantially reduces false positives in untargeted nifedipine metabolite profiling. Analytica Chimica Acta, 1376:344615. (SCIE)
Wang JH*, Lu HC, Wu ZH, Chang TC (2025-08). Integrative Analysis of BMI and Gene Expression Reveals Molecular Interactions Underlying Cancer Progression. Frontiers in Bioscience-Landmark, 30(8):43294. (SCIE)
專書
專題研究計畫
高維度之存活基因資料下強韌肯德爾相關係數之變數篩選研究. 108-2118-M035-004-MY2. Project Period: 2019/10/01~2021/07/31.
高維度之存活基因資料,利用兩個穩健方法執行基因-環境交互作用變數篩選. 110-2118-M035-001-MY2 . Project Period: 2021/08/01~2023/07/31.
基於多元邏輯斯回歸模型的生物標誌物通過重疊群組篩選過程進行癌症診斷並應用於美國癌症基因組圖譜數據. 112-2118-M-194 -003 -MY2. Project Period: 2023/08/01~2025/07/31.
配對病例對照研究的美國癌症基因體圖譜計劃之高維度轉錄組數據的正則化和癌變分類之系統性分析. 114-2118-M-194 -003 -. Project Period: 2025/08/01~2026/07/31.
專題研究計畫(共同主持人)
發展以高效液相層析質譜為基礎的代謝體資料處理方法鑑定藥物代謝物之新策略. 110-2320-B-705-001-. Project Period: 2021/08/01~2022/07/31.
發展以高效液相層析質譜為基礎的代謝體資料處理方法鑑定藥物代謝物之新策略(I). 112-2320-B-705-001-. Project Period: 2023/08/01~2024/07/31.
發展以高效液相層析質譜為基礎的代謝體資料處理方法鑑定藥物代謝物之新策略(II). 113-2320-B-705-001-. Project Period: 2024/08/01~2025/07/31.
發展以高效液相層析質譜為基礎的代謝體資料處理方法鑑定藥物代謝物之新策略(III). 114-2320-B-705-001-. Project Period: 2025/08/01~2026/07/31.